1 – 10 of 76
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Enteral supplementation with arachidonic and docosahexaenoic acid and pulmonary outcome in extremely preterm infants
(
- Contribution to journal › Article
-
Mark
Treatment for retinopathy of prematurity in Sweden 2008–2021 : Reduced gestational age of treated infants and remaining differences in treatment type and recurrence rates between hospitals
(
- Contribution to journal › Article
-
Mark
Ophthalmological outcome of 6.5 years children treated for retinopathy of prematurity : A Swedish register study
(
- Contribution to journal › Article
-
Mark
Arachidonic acid and docosahexaenoic acid levels correlate with the inflammation proteome in extremely preterm infants
(
- Contribution to journal › Article
- 2023
-
Mark
Hyper high haemoglobin content in red blood cells and erythropoietic transitions postnatally in infants of 22 to 26 weeks' gestation: a prospective cohort study
(
- Contribution to journal › Article
-
Mark
Allt fler barn födda före vecka 24 överlever, men sjukligheten är hög
(
- Contribution to specialist publication or newspaper › Specialist publication article
-
Mark
Evaluation of recombinant human IGF‑1/IGFBP‑3 on intraventricular hemorrhage prevention and survival in the preterm rabbit pup model
(
- Contribution to journal › Article
-
Mark
The development of blood protein profiles in extremely preterm infants follows a stereotypic evolution pattern
(
- Contribution to journal › Article
-
Mark
Visual outcome at 2.5 years of age in ω-3 and ω-6 long-chain polyunsaturated fatty acid supplemented preterm infants : a follow-up of a randomized controlled trial
(
- Contribution to journal › Article
-
Mark
Modification of serum fatty acids in preterm infants by parenteral lipids and enteral docosahexaenoic acid/arachidonic acid : A secondary analysis of the Mega Donna Mega trial
(
- Contribution to journal › Article